-
Mashup Score: 8Oliver Dorigo, MD @Stanford @StanfordCancer @imv_inc #A - 2 year(s) ago
Oliver Dorigo, MD, Principal Investigator of the DeCidE1 study and Director of the Gynecologic Oncology Service at Stanford University speaks about the IMV
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Podcast - Oliver Dorigo, MD @Stanford @StanfordCancer @ - 2 year(s) ago
Oliver Dorigo, MD, Principal Investigator of the DeCidE1 study and Director of the Gynecologic Oncology Service at Stanford University speaks about the IMV
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Podcast - DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer and the updated data from ESMO 2021 Oliver Dorigo, MD @Stanford @StanfordCancer @imv_inc #ASCOPubs #ESMO2021 #OvarianCancer #Cancer Link to Audio: https://t.co/fpKtp0LuYD...?channelName=cancernewsupdate https://t.co/3wwMaO061K
-
-
Mashup Score: 0David H. Ilson, MD @ILSONDavid @sloan_kettering @mskcc - 3 year(s) ago
David H. Ilson, MD, Ph.D., FASCO from Memorial Sloan Kettering Cancer Center speaks about the 34 ASCO members receive fellows distinction.Link to Distincti
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
34 ASCO Members Receive Fellows Distinction David H. Ilson, MD @ILSONDavid @sloan_kettering @mskcc #ASCOPubs #Distinction #Cancer #Research https://t.co/QipfG03PtK https://t.co/yQpvdpXd9U
-
-
Mashup Score: 2Samuel R. Denmeade, MD @hopkinskimmel #ASCOPubs #Metast - 3 year(s) ago
Samuel R. Denmeade, MD of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins discusses TRANSFORMER: A Randomized Phase II Study Comparing Bipol
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
TRANSFORMER: A Randomized Phase II Study - Prostate Cancer Samuel R. Denmeade, MD @hopkinskimmel #ASCOPubs #MetastaticProstateCancer #ProstateCancer #Cancer #Research Link To FULL Video: https://t.co/pLY1WXUiIF https://t.co/xLX2CaXmqp
-
-
Mashup Score: 2Cathy Eng, MD @CathyEngMD @VUMC_Cancer @aparna1024 #Rya - 3 year(s) ago
Cathy Eng, MD, FACP, FASCO from Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center speaks about the Editorial – BRAF Mutation in Colorect
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Editorial - BRAF Mutation in Colorectal Cancer: An Enigmatic Target Cathy Eng, MD @CathyEngMD @VUMC_Cancer @aparna1024 #RyanCorcoran #BRAF #ColorectalCancer #ASCOPubs #Cancer #Research Link To FULL Video: https://t.co/82duRZ7Cyv https://t.co/g5KMffJKmq
-
-
Mashup Score: 0Prof. Michael Boyer @MichaelBoyer1 @COBLH @Sydney_Uni # - 3 year(s) ago
Prof. Michael Boyer of the Chris O’Brien Lifehouse and the University of Sydney discusses Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–S
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Randomized, Double-Blind Phase III KEYNOTE-598 Study Prof. Michael Boyer @MichaelBoyer1 @COBLH @Sydney_Uni #NSCLC #LungCancer #ASCOPubs #Cancer #Research Link To FULL Video: https://t.co/h3FipFlr1i https://t.co/EtdAJn2Xm8
-
DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer and the updated data from ESMO 2021 Oliver Dorigo, MD @Stanford @StanfordCancer @imv_inc #ASCOPubs #ESMO2021 #OvarianCancer #Cancer #Research https://t.co/YW16hP7X1S...?channelName=cancernewsupdate https://t.co/Jc8GjSjHSF